Loading clinical trials...
Loading clinical trials...
Atherosclerosis Intervention With Novel Tissue Selective Estrogen Complex Therapy
Conditions
Interventions
Oral bazedoxifene 20 mg / conjugated estrogens 0.45 mg
Placebo
Locations
1
United States
University of Southern California Atherosclerosis Research Unit
Los Angeles, California, United States
Start Date
April 13, 2021
Primary Completion Date
October 31, 2026
Completion Date
December 31, 2026
Last Updated
December 5, 2024
NCT07241390
NCT01143454
NCT07457138
NCT05316311
NCT02932176
NCT06397469
Lead Sponsor
University of Southern California
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions